Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · IEX Real-Time Price · USD
0.347
+0.023 (7.21%)
At close: Jul 2, 2024, 4:00 PM
0.348
+0.002 (0.43%)
After-hours: Jul 2, 2024, 7:57 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $766.21 million as of July 2, 2024. Its market cap has decreased by -78.39% in one year.
Market Cap
766.21M
Enterprise Value
160.26M
1-Year Change
-78.39%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since February 24, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.35B to $766.21M, a decrease of -67.34%. That is a compound annual growth rate of -28.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 714.20M | -80.05% |
| Dec 29, 2023 | 3.58B | 9.20% |
| Dec 30, 2022 | 3.28B | -73.46% |
| Dec 31, 2021 | 12.35B | 426.63% |
| Feb 24, 2021 | 2.35B | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cogent Biosciences | 787.85M |
| Aurinia Pharmaceuticals | 776.59M |
| Viridian Therapeutics | 776.08M |
| CareDx | 776.05M |
| Dianthus Therapeutics | 771.01M |
| CureVac | 749.18M |
| 89bio | 747.72M |
| Harrow Health | 737.71M |